Interaction of C60-Fullerene and Carboxyfullerene with Proteins: Docking and Binding Site Alignment
- 22 February 2006
- journal article
- research article
- Published by American Chemical Society (ACS) in Bioconjugate Chemistry
- Vol. 17 (2) , 378-386
- https://doi.org/10.1021/bc050299g
Abstract
The unique properties of fullerenes have raised the interest of using them for biomedical applications. Within this framework, the interactions of fullerenes with proteins have been an exciting research target, yet little is known about how native proteins can bind fullerenes, and what is the nature of these interactions. Moreover, though some proteins have been shown to interact with fullerenes, up to date, no crystal structure of such complexes was obtained. Here we report docking studies aimed at examining the interactions of fullerene in two forms (C60 nonsubstituted fullerene and carboxyfullerene) with four proteins that are known to bind fullerene derivatives: HIV protease, fullerene-specific antibody, human serum albumin, and bovine serum albumin. Our work provides docking models with detailed binding pockets information, which closely match available experimental data. We further compare the predicted binding sites using a novel multiple binding site alignment method. A high similarity between the physicochemical properties and surface geometry was found for fullerene's binding sites of HIV protease and the human and bovine serum albumins.Keywords
This publication has 18 references indexed in Scilit:
- Identification of the N-terminal Peptide Binding Site of Glucose-regulated Protein 94Journal of Biological Chemistry, 2004
- Trisamine C60-Fullerene Adducts Inhibit Neuronal Nitric Oxide Synthase by Acting as Highly Potent Calmodulin AntagonistsArchives of Biochemistry and Biophysics, 2002
- Optimizing the Binding of Fullerene Inhibitors of the HIV-1 Protease through Predicted Increases in Hydrophobic DesolvationJournal of Medicinal Chemistry, 1998
- Blockage of apoptotic signaling of transforming growth factor‐β in human hepatoma cells by carboxyfullereneEuropean Journal of Biochemistry, 1998
- Determination of atomic desolvation energies from the structures of crystallized proteinsJournal of Molecular Biology, 1997
- Anti-human immunodeficiency virus activity and cytotoxicity of derivatized buckminsterfullerenesBioorganic & Medicinal Chemistry Letters, 1996
- CLUSTAL W: improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choiceNucleic Acids Research, 1994
- Photoinduced biochemical activity of fullerene carboxylic acidJournal of the American Chemical Society, 1993
- Inhibition of the HIV-1 protease by fullerene derivatives: model building studies and experimental verificationJournal of the American Chemical Society, 1993
- C60: BuckminsterfullereneNature, 1985